Prudential PLC Has $333,000 Stock Holdings in DaVita Inc. $DVA

Key Points

• Prudential PLC reduced its holdings in DaVita Inc. by 71.5%, ending the first quarter with a position worth $333,000 after selling over 5,400 shares.
• Fifth Third Bancorp and other large investors have recently increased their stakes in DaVita, highlighting a mixed sentiment among institutional investors, who collectively own 90.12% of the company's stock.
• DaVita reported $2.95 earnings per share for the last quarter, beating estimates and showing a 6.1% year-over-year revenue growth.

Prudential PLC cut its stake in DaVita Inc. (NYSE:DVA - Free Report) by 71.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,175 shares of the company's stock after selling 5,449 shares during the quarter. Prudential PLC's holdings in DaVita were worth $333,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of DVA. Epoch Investment Partners Inc. bought a new stake in DaVita during the 4th quarter worth approximately $55,100,000. Iron Triangle Partners LP bought a new stake in DaVita during the 4th quarter worth approximately $38,946,000. GAMMA Investing LLC increased its stake in DaVita by 14,695.8% during the 1st quarter. GAMMA Investing LLC now owns 234,809 shares of the company's stock worth $35,919,000 after purchasing an additional 233,222 shares in the last quarter. Nuveen LLC bought a new stake in DaVita during the 1st quarter worth approximately $20,218,000. Finally, Rovin Capital UT ADV bought a new stake in DaVita during the 1st quarter worth approximately $18,442,000. 90.12% of the stock is owned by institutional investors.

Insider Transactions at DaVita

In other DaVita news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction on Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.50% of the stock is owned by corporate insiders.

Analyst Ratings Changes

DVA has been the subject of several research reports. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, April 25th. Barclays decreased their price target on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Finally, Truist Financial set a $148.00 price target on shares of DaVita in a research note on Friday, August 8th. Three analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, DaVita has an average rating of "Hold" and a consensus target price of $164.00.

DaVita Stock Up 0.6%

Shares of NYSE DVA traded up $0.8450 during trading hours on Thursday, hitting $138.2650. The company had a trading volume of 309,972 shares, compared to its average volume of 860,121. The stock has a market capitalization of $9.89 billion, a P/E ratio of 13.60, a price-to-earnings-growth ratio of 0.98 and a beta of 1.09. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 1-year low of $126.07 and a 1-year high of $179.60. The firm's 50 day moving average is $139.54 and its 200-day moving average is $144.65.

DaVita (NYSE:DVA - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 EPS for the quarter, beating the consensus estimate of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same quarter in the prior year, the firm posted $2.00 EPS. The firm's revenue for the quarter was up 6.1% compared to the same quarter last year. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, analysts expect that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.